quarta-feira, 8 de maio de 2013

Boletín de PANAFTOSA - Fiebre Aftosa No. 18


Diarrea Bovina Viral / Bovine Viral Diarrhea Viruses

Competitive virus assay method for titration of noncytopathogenic bovine viral diarrhea viruses (END+ and END- viruses). Muhsen M, Ohi K, Aoki H, Ikeda H, Fukusho A. J Virol Methods. 2013 Mar; 188 (1-2): 6-12




Fiebre Aftosa / Foot and Mouth Disease

Co-inoculation of baculovirus and FMDV vaccine in mice, elicits very early protection against foot and mouth disease virus without interfering with long lasting immunity. Quattrocchi V, Molinari P, Langellotti C, Gnazzo V, Taboga O, Zamorano P. Vaccine. 2013 Apr 



Control of foot-and-mouth disease during 2010-2011 epidemic, South Korea. Park JH, Lee KN, Ko YJ, Kim SM, Lee HS, Shin YK, Sohn HJ, Park JY, Yeh JY, Lee YH, Kim MJ, Joo YS, Yoon H, Yoon SS, Cho IS, Kim B. Emerg Infect Dis. 2013 Apr; 19 (4): 655-9



Detection of foot-and-mouth disease serotype O by ELISA using a monoclonal antibody. Chen HT, Peng YH, Zhang YG, Liu XT. Monoclon Antib Immunodiagn Immunother. 2013 Feb; 32 (1):47-9




Development and evaluation of multiplex RT-LAMP assays for rapid and sensitive detection of foot-and-mouth disease virus. Yamazaki W, Mioulet V, Murray L, Madi M, Haga T, Misawa N, Horii Y, King DP. J Virol Methods. 2013 Apr



Development of a quick and simple detection methodology for foot-and-mouth disease virus serotypes O, A and Asia 1 using a generic rapid assay device. Yang M, Goolia M, Xu W, Bittner H, Clavijo A. Virol J. 2013 Apr; 10 (1): 125



Enhancement of the immune responses to foot-and-mouth disease vaccination in mice by oral administration of a Novel polysaccharide from the roots of Radix Cyathulae officinalis Kuan (RC). Feng H, Du X, Tang J, Cao X, Han X, Chen Z, Chen Y, Zeng X. Cell Immunol. 2013 Mar; 281 (2):111-121



Foot and mouth disease virus-loaded fungal chitosan nanoparticles for intranasal administration: impact of formulation on physicochemical and immunological characteristics. Tajdini F, Amini MA, Mokarram AR, Taghizadeh M, Azimi SM. Pharm Dev Technol. 2013 Apr 



Foot-and-mouth disease virus modulates cellular vimentin for virus survival. Gladue DP, O'Donnell V, Baker-Branstetter R, Holinka LG, Pacheco JM, Sainz IF, Lu Z, Ambroggio X, Rodriguez L, Borca MV. J Virol. 2013 Apr 





Induction of partial protection against foot and mouth disease virus in guinea pigs by neutralization with the Integrin ß6-1 Subunit. Zhang Y, Sun Y, Yang F, Guo J, He J, Wu Q, Cao W, Lv L, Zheng H, Zhang Z. Viruses. 2013 Apr; 5 (4): 1114-30



Nucleotide mismatches of foot-and-mouth disease virus during replication. Ma YB, Hao CX, Chang HY. Genet Mol Res. 2013 Apr; 12 (2): 1022-7




Rational engineering of recombinant picornavirus capsids to produce safe, protective vaccine antigen. Porta C, Kotecha A, Burman A, Jackson T, Ren J, Loureiro S, Jones IM, Fry EE, Stuart DI, Charleston B. PLoS Pathog. 2013 Mar; 9 (3):e1003255



Repeated exposure to 5D9, an inhibitor of 3D polymerase, effectively limits the replication of foot-and-mouth disease virus in host cells. Rai DK, Schafer E, Singh K, McIntosh MA, Sarafianos SG, Rieder E. Antiviral Res. 2013 Apr 



Requirements for improved vaccines against foot-and-mouth disease epidemics. Park JH. Clin Exp Vaccine Res. 2013 Jan; 2 (1):8-18




VP1 protein of foot-and-mouth disease virus (FMDV) impairs baculovirus surface display. Peralta A, Maroniche GA, Alfonso V, Molinari P, Taboga O. Virus Res. 2013 Apr




Destacados

Nenhum comentário:

Postar um comentário